Color Genomics Revenue and Competitors

Color’s mission is to help people lead the healthiest lives that science and medicine can offer. We launched in April 2015 with a simple, affordable genetic test to help people understand their risk for hereditary cancer. In 2017, we added coverage for hereditary heart conditions. Between them, cancer and heart disease constitute the two biggest causes of death worldwide. In September 2018, we introduced a new health area, medication response, to help people understand how their genes may influence response to certain medications. By combining state-of-the-art software with clinical genomics, we’re building a personal health service that helps people benefit from the information in their own bodies. Early detection helps individuals create preventative plans with their doctors using appropriate screening guidelines relative to their personal and familial risk of certain diseases including cancer and heart disease. We’re an early stage company making a huge impact in people’s lives. We’ve built a best in class team from Google, Dropbox, Pinterest and Twitter. Our product work is uniquely interdisciplinary - teams include scientists, doctors, designers, robotics engineers, and PMs. Lastly, we’re empowered by amazing investors including General Catalyst, Khosla Ventures, Sundar Pichai, Laurene Powell-Jobs, Aaron Levie and Padmasree Warrior.